Free Trial
→ Prepare for the “Mar-a-Lago Accord” Money Shock (From Stansberry Research) (Ad)tc pixel Free IKT Stock Alerts

Inhibikase Therapeutics (IKT) SEC Filings & 10K Form

Inhibikase Therapeutics logo
$1.64 +0.10 (+6.49%)
Closing price 09/19/2025 04:00 PM Eastern
Extended Trading
$1.64 +0.01 (+0.30%)
As of 07:10 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Inhibikase Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/28/2025
6:48 PM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2025
6:50 PM		Aurentz Vincent (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 3/A
08/28/2025
6:52 PM		Cabell Christopher (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 3/A
08/14/2025
7:27 PM		ADAR1 Capital Management, LLC (Filed by)
Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
Form SCHEDULE 13G/A
08/14/2025
4:06 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2025
10:17 AM		Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
Sands Capital Life Sciences Pulse Fund II, L.P. (Filed by)
Form SCHEDULE 13G/A
07/15/2025
10:15 AM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Sands Capital Alternatives, LLC (Reporting)
Sands Capital Life Sciences Pulse Fund II, L.P. (Reporting)
SANDS FRANK M. (Reporting)
Form 3/A
07/02/2025
6:55 PM		Aurentz Vincent (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 4/A
07/02/2025
6:56 PM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Iwicki Mark T (Reporting)
Form 4/A
07/02/2025
7:00 PM		Cabell Christopher (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 4/A
07/02/2025
6:38 PM		Bellini Roberto (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
6:40 PM		BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
6:41 PM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Kush Arvind (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
6:43 PM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
6:48 PM		Canner David (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
6:49 PM		Aurentz Vincent (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2025
11:15 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form EFFECT
06/20/2025
4:06 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/14/2025
4:29 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2025
4:06 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2025
3:05 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form PRE 14A
04/14/2025
7:16 AM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2025
4:01 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/24/2025
7:14 AM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
7:16 PM		Freeman Roy Lester (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:18 PM		Bellini Roberto (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:19 PM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Kush Arvind (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:24 PM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Iwicki Mark T (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/19/2025
7:26 PM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Iwicki Mark T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:00 PM		BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:06 PM		BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 4/A
02/19/2025
7:11 PM		Canner David (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:11 PM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:09 AM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
8:04 PM		ADAR1 Capital Management, LLC (Filed by)
Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
Form SCHEDULE 13G
02/14/2025
4:35 PM		ARMISTICE CAPITAL, LLC (Filed by)
Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
Form SCHEDULE 13G/A
02/14/2025
2:45 PM		Fairmount Funds Management LLC (Filed by)
Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
Form SCHEDULE 13G/A
02/04/2025
3:06 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/29/2025
3:05 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
3:05 PM		BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
3:05 PM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Werner Milton H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
3:05 PM		Freeman Roy Lester (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
3:05 PM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Lees-Rolfe Garth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
11:15 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form EFFECT
01/10/2025
3:37 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/07/2025
5:39 PM		Freeman Roy Lester (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
5:43 PM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Lees-Rolfe Garth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
5:47 PM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Werner Milton H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
5:38 PM		BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:06 AM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
11:15 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form EFFECT
12/05/2024
3:47 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form 424B3
12/05/2024
3:50 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
5:24 AM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form S-3/A
11/18/2024
3:49 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/14/2024
7:30 AM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
3:07 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form PRE 14A
10/28/2024
4:26 PM		Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
SP IKT Holdings LLC (Filed by)
Form SC 13G
10/28/2024
3:00 PM		Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
Soleus Private Equity Fund III, L.P. (Filed by)
Form SC 13G
10/25/2024
4:52 PM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Sands Capital Life Sciences Pulse Fund II, L.P. (Reporting)
Sands Capital Ventures, LLC (Reporting)
SANDS FRANK M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/25/2024
4:50 PM		Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
Sands Capital Life Sciences Pulse Fund II, L.P. (Filed by)
Form SC 13G
10/23/2024
6:58 PM		Canner David (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
6:35 PM		Bellini Roberto (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2024
6:36 PM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Munshi Amit (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2024
6:38 PM		Canner David (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2024
6:40 PM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Kush Arvind (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2024
6:43 PM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
6:49 PM		Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Kush Arvind (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
6:53 PM		Bellini Roberto (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
3:15 PM		Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G
10/21/2024
8:13 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
6:00 PM		Fairmount Funds Management LLC (Filed by)
Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
Form SC 13G
10/17/2024
3:05 PM		COMMODORE CAPITAL LP (Filed by)
Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
Form SC 13G
10/10/2024
4:31 PM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
7:40 AM		Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:IKT) was last updated on 9/22/2025 by MarketBeat.com Staff
From Our Partners
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...
Investors Alley | Sponsoredtc pixel
College grad makes $64,000 a month
A Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...
Stansberry Research | Sponsoredtc pixel
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...
Paradigm Press | Sponsoredtc pixel
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsoredtc pixel
Washington prepares for war
While the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...
Porter & Company | Sponsoredtc pixel
This soon could be the most precious company in America
AI is devouring power at an unprecedented rate. Google alone expects its annual electricity bill to jump by $2...
True Market Insiders | Sponsoredtc pixel
Claim Your Share of $5.39 BILLION in AI Equity Checks
The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...
Angel Publishing | Sponsoredtc pixel
Forget AI Stocks — This Device Will REPLACE the Microchip
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...
Banyan Hill Publishing | Sponsoredtc pixel